Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Clin Sci (Lond) ; 134(23): 3093-3106, 2020 12 11.
Artigo em Inglês | MEDLINE | ID: mdl-33206153

RESUMO

Acute Kidney Injury (AKI) comprises a rapidly developed renal failure and is associated with high mortality rates. The Renin-Angiotensin System (RAS) plays a pivotal role in AKI, as the over-active RAS axis exerts major deleterious effects in disease progression. In this sense, the conversion of Angiotensin II (Ang II) into Angiotensin-(1-7) (Ang-(1-7)) by the Angiotensin-converting enzyme 2 (ACE2) is of utmost importance to prevent worse clinical outcomes. Previous studies reported the beneficial effects of oral diminazene aceturate (DIZE) administration, an ACE2 activator, in renal diseases models. In the present study, we aimed to evaluate the therapeutic effects of DIZE administration in experimental AKI induced by gentamicin (GM) in rats. Our findings showed that treatment with DIZE improved renal function and tissue damage by increasing Ang-(1-7) and ACE2 activity, and reducing TNF-α. These results corroborate with a raising potential of ACE2 activation as a strategy for treating AKI.


Assuntos
Injúria Renal Aguda/tratamento farmacológico , Injúria Renal Aguda/enzimologia , Enzima de Conversão de Angiotensina 2/metabolismo , Diminazena/análogos & derivados , Ativadores de Enzimas/farmacologia , Gentamicinas/efeitos adversos , Rim/patologia , Substâncias Protetoras/uso terapêutico , Injúria Renal Aguda/fisiopatologia , Injúria Renal Aguda/urina , Animais , Biomarcadores/metabolismo , Peso Corporal/efeitos dos fármacos , Citocinas/metabolismo , Diminazena/farmacologia , Diminazena/uso terapêutico , Inflamação/patologia , Rim/efeitos dos fármacos , Rim/fisiopatologia , Masculino , Substâncias Protetoras/farmacologia , Ratos Wistar , Sistema Renina-Angiotensina
2.
J Biomed Mater Res A ; 109(7): 1051-1064, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-32876363

RESUMO

Bioactive glasses (BGs) have shown great potential for tissue regeneration and their composition flexibility allows the incorporation of different ions with physiological activities and therapeutic properties in the glass network. Among the many ions that could be incorporated, cobalt (Co) is a significant one, as it mimics hypoxia, triggering the formation of new blood vessels by the vascular endothelial growth factor A (VEGFA), due to the stabilizing effect on the hypoxia inducible factor 1 subunit alpha (HIF1A), an activator of angiogenesis-related genes, and is therefore of great interest for tissue engineering applications. However, despite its promising properties, the effects of glasses incorporated with Co on angiogenesis, through human umbilical cord vein endothelial cells (HUVECs) studies, need to be further investigated. Therefore, this work aimed to evaluate the biocompatibility and angiogenic potential of a new sol-gel BG, derived from the SiO2 -CaO-P2 O5 -CoO system. The structural evaluation showed the predominance of an amorphous glass structure, and the homogeneous presence of cobalt in the samples was confirmed. in vitro experiments showed that Co-containing glasses did not affect the viability of HUVECs, stimulated the formation of tubes and the gene expression of HIF1A and VEGFA. in vivo experiments showed that Co-containing glasses stimulated VEGFA and HIF1A expression in blood vessels and cell nuclei, respectively, in the deep dermis layer of the dorsal region of rats, featuring considerable local stimulation of the angiogenesis process due to Co-release. Co-containing glasses showed therapeutic effect, and Co incorporation is a promising strategy for obtaining materials with superior angiogenesis properties for tissue engineering applications.


Assuntos
Materiais Biomiméticos/química , Cobalto/química , Vidro/química , Fator 1 Induzível por Hipóxia/análise , Neovascularização Fisiológica , Fator A de Crescimento do Endotélio Vascular/análise , Animais , Materiais Biocompatíveis/química , Materiais Biocompatíveis/farmacologia , Materiais Biomiméticos/farmacologia , Cobalto/farmacologia , Células Endoteliais da Veia Umbilical Humana , Humanos , Masculino , Neovascularização Fisiológica/efeitos dos fármacos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA